The number of new lung cancer cases attributable to workplace ETS exposure in France was estimated with regard to the following factors: excess risk of lung cancer from workplace ETS exposure, incidence of lung cancer in non-exposed non-smokers, and number of French workers exposed to passive smoking. The excess risk of lung cancer from workplace ETS exposure was estimated as from 0.12 to 0.39 by different references. The French workforce, regularly exposed to ETS in their workplace is about 3.2 millions. The incidence of lung cancer of nonsmokers without exposure to ETS is between 3.7 to 10 per hundred thousand. If these three factors are combined, it is estimated that exposure to workplace passive smoking causes around 14 to 125 new cases of lung cancer each year in France. New lung cancer cases from workplace exposure to ETS represent a few percent of all occupational lung cancers, and a minuscule number in regards to the whole lung cancer annual incidence (14 to 125 for 23,000 lung cancers in France=0.06% to 0.54%) (J Occup Health 2006; 48: 329-331) 
Only a few studies have examined the relationship between occupational environmental tobacco smoke (ETS) exposure and lung cancer [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . The aim of this study was to estimate the excess number of new lung cancer cases from occupational ETS exposure in France.
Methods
The number of new lung cancer cases from workplace ETS exposure in France was estimated considering three factors.
Excess risk
All studies concerning excess risk of lung cancer from ETS exposure were identified through online literature searches (e.g. Medline and Toxline). We searched metaanalysis and review articles which were published between January 1995 and March 2004. Six meta-analyse and one review article were accepted for our study with regard to international publications [11] [12] [13] [14] [15] [16] [17] . Furthermore, published reports of authoritative organizations, such as the International Agency for Research on Cancer (IARC) 18) , the Environmental Protection Agency (EPA) 1) and the Scientific Committee on Tobacco and Health (SCOTH) 19) were also collected.
Lung cancer incidence
Lung cancer incidence in non-smokers who were not exposed to ETS was determined by Medline search and data collection from other studies (e.g. SCOTH report). We have accepted the incidence rate applied by SCOTH 19) for the high hypothesis, and the one declared by Boffetta et al. 20) for the low hypothesis of our study.
Exposed population
We defined the exposed population, as only nonsmoking workers regularly exposed to inhalation of ETS at their workplace (all commercial or industrial branches were concerned). Low frequencies of ETS exposure, for example, two or three times a year were neglected. The information about the active French population exposed to ETS in their workplace was estimated from the latest French publications 21, 22) .
Methodology calculation
Annual incidence of lung cancer from workplace ETS exposure was estimated with this equation: (Excess risk of lung cancer from ETS exposure in the workplace) × (Risk of lung cancer in non-exposed non-smokers) × (French active population exposed to workplace passive smoking).
Results and Discussion

ETS exposure and lung cancer
A statistically significant increased risk of lung cancer of 12% to 39% in non-smokers exposed to second hand tobacco smoke at the workplace was found 23, 24) .
Risk of lung cancer in non-exposed non-smokers
This incidence was estimated as being from about 3.7/ 100,000 to 10/100,000 by other studies 19, 20) . The incidence of lung cancer in non-smokers without exposure to ETS is 10 per 100,000. An increased risk of lung cancer from 12 to 39% in exposed non-smokers would give a lung cancer incidence of 11.2 to 13.9 cases per 100,000 per year. In other words we could expect an additional 1.2 to 3.9 lung cancer cases each year per 100,000 non-smokers regularly exposed to ETS in their workplace.
Exposed French population
The number of French persons, regularly exposed to occupational ETS, has not been calculated precisely. Kauppinen et al. 25) declare that ETS is the most common occupational respiratory carcinogen in European Union countries such as France, in which about 1.2 million of workers are exposed to ETS. The authors of the abovementioned investigation only considered workers who were exposed to ETS for more than 75% of their working time. This is why the real number of French workers who are exposed to ETS in their workplace must be more than 1,200,000.
For our estimation (data obtained, as occupational practitioner, from a sample of 2,000 workers) we have assumed that about 20% of French non-smoker workers are regularly exposed to occupational ETS. The French non-smoker active population is about 16 millions 26, 27) (total French working population is 25 millions). Therefore we estimated that about 3,200,000 of French workers are regularly exposed to occupationally passive smoking.
Lung cancer incidence attributable to workplace ETS exposure
As mentioned previously, according to different investigations, excess risk of lung cancer from ETS exposure in the workplace has been estimated as being between 12% and 39%, and the incidence of lung cancer in non-exposed non-smokers has been determined as being between 3.5/100,000 and 10/10,000, yearly. Considering 3,200,000 French non-smoker workers who are regularly exposed to ETS in their workplace, we estimated that: 3,200,000 × (3.5/100,000-10/100,000) × (12%-39%)=14-125 new cases of lung cancer are found yearly for the reason of workplace ETS exposure in France (Table 1) .
It is estimated that approximately 50% of the daily ETS exposure is attributed to workplace exposure 28) . The principal limitation of our study is the number of French workers who are exposed to workplace passive smoking. As mentioned above, there is no precise figure for this number. We determined this number using existing data.
The total number of lung cancers due to occupational exposures among men in France is estimated to be about 2,713-6,051 new cases, yearly 29) . In other words, the estimated number of lung cancer for occupational ETS exposure in France is only a few percent of the total number of occupational lung cancers (0.2% to 4%).
With regard to the fact that ETS is the most common occupational exposure to group 1 respiratory carcinogens in European Union countries (e.g. France), the necessity of approving a more effective and appropriate law seems obvious. 
